MC38-hFOLR1/hCD47(2)

Export PDF

Strain Information

Validation Data

image.png

Fig1. Analysis of hFOLR1 and hCD47 expression in in vitro cultured MC38-hFOLR1/hCD47 cells by FACS.

image.pngFig2. In vivo validation of MC38-hFOLR1/hCD47 in C57BL/6 mice. C57BL/6 mice were inoculated with MC38-hFOLR1/hCD47 subcutaneously at 1×106 cells /mouse inoculum for tumor development.

image.png

Fig3. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice. The tumors were collected at day 25 post tumor cell inoculation.

image.png

Fig4. hFOLR1 and hCD47 expression in tumors after in vivo growth of MC38-hFOLR1/hCD47 in wild type C57BL/6 mice. The tumors were collected at day 35 post tumor cell inoculation.


Related Strain(s)

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn more